跳至主要内容
临床试验/NCT05658835
NCT05658835招募中不适用

Interest of Molecular Analysis of Cerebral Thrombi in Determining the Prognosis and Etiology of Cerebral Infarction

Assistance Publique Hopitaux De Marseille4 个研究点 分布在 1 个国家目标入组 311 人开始时间: 2023年2月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
311
试验地点
4
主要终点
Determination and validation of molecular signatures, obtained by LC-MS analysis of cerebral thrombi, predictive of the excellent clinical prognosis

研究概览

简要总结

The MATISSE (Molecular Analysis of Thrombus for Ischemic Stroke prognosis and Etiology) project evaluates the hypothesis that the molecular composition of cerebral thrombus in metabolites, lipids, and proteins conditions the clinical prognosis at 3 months of the infarction and informs on its etiological subtype

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female 18 years of age or older;
  • Patient with a cerebral infarction documented by brain imaging who received endovascular treatment by mechanical thrombectomy;
  • Patient for whom it was possible to collect cerebral thrombus for LC-MS analysis during mechanical thrombectomy:
  • Patient who was informed of the study and formulated a non-opposition to participation. If not, patient for whom a relative was informed and formulated a non-opposition.

排除标准

  • Patient with a cerebral infarction documented by cerebral imaging, having benefited from an endovascular treatment with mechanical thrombectomy that did not allow the extraction of a cerebral thrombus.
  • Protected persons (articles L1121-5, L1121-6 and L121-8 of the Public Health Code): pregnant or breast-feeding women, persons deprived of liberty, under guardianship or curatorship

结局指标

主要结局

Determination and validation of molecular signatures, obtained by LC-MS analysis of cerebral thrombi, predictive of the excellent clinical prognosis

时间窗: 3 months after the cerebral infarction

Rankin score (0 to 6, 6 meaning worse outcome)

次要结局

  • Use of thrombolytic therapy in the acute phase(Before thrombectomy)
  • Positive infarct growth after successful recanalization(Between 24 and 48h after the thrombectomy)
  • Severe intracranial hemorrhage(3 months after the cerebral infarction)
  • Death(3 months after cerebral infarction)
  • Patient exposure to peak outdoor air pollution(96 hours before cerebral infarction)
  • Early Neurological Deterioration(24 hours after recanalization treatment)
  • Determination and validation of molecular signatures, obtained by LC-MS analysis(3 months after the cerebral infarction)
  • Recovery of autonomy in walking(7 days after the cerebral infarction)
  • Determination of molecular signatures predictive on successful recanalization after mechanical thrombectomy(Right after the thrombectomy)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验